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OBJECTIVES: Diagnosis related groups (DRG) like financing method was introduced 
in Hungary in 1993 for acute care hospital reimbursement. Due to the increased 
activity of the hospitals, an upper ceiling, the so called performance volume limit 
(PVL) was introduced in acute care hospital financing in 2006. The aim of our study 
was to analyze the effect of performance volume limit on DRG based hospital financ-
ing on the example of a Hungarian tertiary teaching hospital, the Clinical Centre 
of the University of Pécs. METHODS: Data derived from the financial database of 
the National Health Insurance Fund Administration, the only health care financing 
agency in Hungary. We analyzed the annual DRG based health insurance revenues 
with and without performance volume limit ceiling. We calculated the proportion 
of hospital activity over that ceiling measured by DRG cost-weights. The period 
2007-2013 was involved into the study. RESULTS: We found a significant loss in 
DRG reimbursement due to performance volume limit. The annual loss in DRG 
reimbursement varied between 2.4-10.5 million USD between 2007-2013. The highest 
revenue loss was observed in 2009, and after 2009 the financial loss decreased to 
7.0 (2010), 5.2 (2011), 3.0 (2012) and 2.8 (2013) million USD. This annual revenue loss 
represented 3.0-14.9 % of the annual revenues of the Clinical Centre of the University 
of Pécs. CONCLUSIONS: The introduction of performance volume limit into the 
DRG based hospital financing resulted in a partial loss of hospitals’ revenues. The 
Clinical Centre of the University of Pécs experienced significant loss its revenues 
due to this regulation.
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OBJECTIVES: Hospitalizations for Ambulatory Care Sensitive Conditions also known 
as preventable hospitalizations can be prevented by proper management in the 
primary care settings. West Virginia (WV) has highest per person preventable hospi-
talization cost as compared to other states. The objective of this study is to examine 
the rates of preventable hospitalizations and patient- and county-level factors that 
may be associated with preventable hospitalizations among Medicaid beneficiaries 
with chronic conditions in WV. METHODS: Longitudinal dynamic cohort design 
with baseline and follow-up years was used. Patient-level data were obtained from 
2007-2010 Medicaid claims files and county-level data were derived from the Area 
Health Resource File for WV. The study population included non-elderly inpatient 
users with selected chronic conditions and 24-months continuous fee-for-service 
enrollment in Medicaid and not enrolled in Medicare (n= 2,938). The dependent vari-
able was any preventable hospitalization in the follow-up year and these were iden-
tified using the Prevention Quality Indicator software developed by the Agency for 
Healthcare Research and Quality. All patient-level (e.g. demographic characteristics, 
healthcare utilization, and care continuity) and county-level factors (e.g. county level 
of healthcare infrastructure) were measured during the baseline. Chi-square tests 
and logistic regressions were used to determine the association between patient- 
and county-level factors and preventable hospitalizations. RESULTS: In this study 
population 65% were women, 96.3% were whites; 18.5% had any preventable hos-
pitalizations; 12.2% had chronic and 7.2% had acute preventable hospitalizations. 
A higher percentage of adults in the age group 35-44 had any preventable hospi-
talization (22.2%) compared to adults in the age-group 25-34 (14.0%). The results 
from multivariable analysis suggest that patients living in the counties with higher 
income were less likely to have acute preventable hospitalizations [AOR= 0.48, 95% 
CI (0.28, 0.83)]. CONCLUSIONS: Economic climate in WV counties may impact the 
risk of acute preventable hospitalizations.
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OBJECTIVES: The purpose of this study is to provide a source document in the 
creation of a dataset for analysis to develop a predictor algorithm for disease man-
agement. METHODS: A review of the literature was performed to determine best 
practices in the development of a dataset to design a predictor model. Algorithms 
improve applicability across health settings to meet various disease management 
aims. Peer reviewed articles and reports were retrieved from the published litera-
ture from 2004 to 2014. To summarize results a case study is also provided related 
to the need for a patient to enroll in a disease state management program based 
on predicting their chance to have a heart attack. RESULTS: Results revealed a 
total of 33 articles and reports. A summary of this information is provided as a 
step-by-step guide on how to setup a dataset to predict disease state management 
patient outcomes. The purpose of data collection should be discussed in detail 
(e.g. collection of data to identify high risk members). Using predictive modeling 
tools, data can be synthesized such as diagnoses, hospitalizations, emergency 
room encounters, expenditures and demographics to develop individualized risk 
profiles. The assessment period and outcomes of interest should be clearly defined 
followed by an analysis of model sensitivity and specificity. Members are assigned 
a chronic illness intensity index score based on these factors. Once scored, mem-
bers are filtered through clinical criteria that prioritize individuals with clinically 
manageable conditions. The resulting list represents those members with the 
most acute and complex illness burden. CONCLUSIONS: Findings from this study 
have implications for clinical care, patient outcomes, research, and policy. Many 
patients are not receiving appropriate preventive care, lack recommended care 
and receive contraindicated care. An increase in the creation of databases to be 
used effectively to develop predictor models is needed to intervene early in the 
disease cycle.
insulin was the predominant type and increased from 38% to 48% of patients 
taking insulin alone or combined with OADs. Patients without prescription claims 
for T2D medication dropped from 48% to 36%. Overall annual costs/T2D patient 
rose by $1466, from $13,743 to $15,175, adjusted to 2012 dollars. CONCLUSIONS: 
For patients in this database, T2D incidence rate decreased from 2007 to 2012, but 
increased pharmacy claims, comorbidity rates and resource utilization expanded 
the clinical and economic burden of managing T2D.
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OBJECTIVES: Approximately 36% of family caregivers help older adults man-
age medications. Caregivers have an extensive unmet need for information and 
training, however, the relationship between caregivers’ assistance in managing 
care-recipients’ medications and their use of training services is unclear. The 
objectives of this study are to examine the association between informal caregiv-
ers’ assistance in managing care-recipients’ medications and their a) receipt and 
b) initiation to seek caregiving-related training. METHODS: A retrospective non-
experimental study was conducted utilizing data from the National Health and 
Aging Trends Study (NHATS), and its supplement, the National Study of Caregiving 
(NSOC). NHATS is comprised of a nationally representative sample of Medicare 
beneficiaries (≥ 65 years) while NSOC includes a sample of their informal caregiv-
ers. Caregiver assistance in managing care-recipients’ medications was assessed 
using an item asking caregivers if they help keep track of care-recipients’ medica-
tions. Use of training services was assessed using two items asking if caregivers 
have received or looked for training to help provide care. Descriptive statistics 
and logistic regression were performed. RESULTS: Fifty four percent of caregiv-
ers (N= 1367) helped keep track of care-recipients’ medications. Approximately 
7% indicated they received training and 10.2% reported looking for training. After 
adjusting for caregivers’ education and gender and care-recipients’ gender, race, 
and number of chronic conditions, the adjusted odds of receiving training were 
2.58 (95% CI: 1.42, 4.69) fold higher for caregivers who kept track of medications. 
The adjusted odds of seeking training were 2.29 (95% CI: 1.36, 3.86) fold higher 
for caregivers who kept track. CONCLUSIONS: Results suggest that relatively few 
caregivers receive or seek training, however, caregivers who manage medications 
are more likely to have training for their care. Future research should examine the 
nature of training and how it impacts caregivers’ ability to manage medications.
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Patients sent to tHe eMergenCy dePartMent by advanCed 
HealtHCare Providers are More likely to need adMission
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OBJECTIVES: We sought to determine whether admission rates (as a marker for 
more essential ED utilization) differed based on the type of outpatient provider 
contact patients experienced prior to their ED visits. METHODS: We performed a 
prospective, cross-sectional survey study of adult ED patients who presented to a 
single tertiary care referral center. Patients were asked whether they had attempted 
to contact healthcare providers prior to their visit, what type of provider, whether 
it was in person or by phone, and what instructions they received. Responses were 
matched with patient disposition. Those seen by a provider or told by phone to go 
the ED were considered “sent” to the ED. Others were considered “self-triaged.” 
Patients were considered to have had an “informed” decision to be sent to the ED if 
they were seen in person or spoke with a physician, as opposed to being sent by a 
nurse or office clerk. Pearson’s Chi-Square testing was used to determine associa-
tions between the type of outpatient provider contact and ED disposition. RESULTS: 
There was no difference in admission rate between those sent to the ED (86/166, 
51%) and those who self-triaged (134/292, 46%). Patients who received an informed 
decision to be sent to the ED were more likely to be admitted (59/99, 60%) than oth-
ers who were sent to the ED (23/61, 38%), p< 0.01. CONCLUSIONS: Patients directed 
to the ED by a physician were more likely to be admitted than those sent in by 
other ancillary staff. Admission rate might be one indicator of patient acuity. This 
indicates that a more informed decision to send patients to the ED may reduce 
avoidable ED utilization. Therefore, improving patients’ access to a physician by 
phone or expanding acute unscheduled care options for assessments may reduce 
ED visits that do not require hospital admission.
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suggest that the community pharmacists in Pakistan do have concerns regarding 
their present clinical and professional role. Besides, this study also suggested that 
community pharmacists need to be more proactive and professional in collaboration 
with other health care professionals.
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OBJECTIVES: To investigate hospital pharmacists’ Knowledge, Attitude and 
Perceptions (KAP) regarding pharmacists-led interventions to reduce Adverse Drug 
Reactions (ADRs), Drug Interactions (DIs), and Pharmaceutical Care Issues (PCIs) 
towards better pharmaceutical care planning in Pakistan. METHODS: A prospective, 
cross-sectional and self-administered questionnaire based study was conducted in 
tertiary care public hospitals in Pakistan. Only registered hospital pharmacists were 
approached to obtain data regarding their KAP towards pharmacists-led interven-
tions to reduce ADRs, DIs, and PCIs towards better pharmaceutical care planning. All 
obtained data were analyzed using descriptive and inferential statistics. RESULTS: 
More than two thirds of the hospital pharmacists (75%) rated physicians as the first 
person to contact in case of any ADRs, DIs, and PCIs. Nevertheless, very poor KAP 
was observed towards pharmacist’s professional role in addressing ADRs, DIs, and 
PCIs (79%). Unexpectedly, 42% of them were not having appropriate knowledge 
towards pharmacists’ role in addressing ADRs, DIs, and PCIs in PCP (79%). A total of 
72.1% reported that they are familiar with the procedure of reporting ADRs. A total 
of 89.1% of the respondents agreed that safe, effective and patient-centered PCP 
plays an important role in patient safety and professional healthcare. In multivari-
ate logistic regression, statistical correlations showed that gender and age were the 
persuasive predictors for the studied model. CONCLUSIONS: The findings from this 
study endorse that the knowledge of hospital pharmacists in Pakistan regarding 
their role to reduce ADRs, DIs, and PCIs towards better pharmaceutical care plan-
ning was not satisfactory. Their attitude towards learning of latest methods and 
procedures to address ADRs, DIs, and PCIs was satisfactory. However, pharmacists 
need to be more proactive and professional in playing their professional role towards 
better patient care.
HealtH Care Use & PoliCy stUdies – drug/device/diagnostic Use & Policy
PHP10
traCking tHe sPonsoring CoUntry of inCorPoration for new drUgs 
aPProved by tHe Us fda in tHe Period 1980-2014: a trend analysis
Alqahtani S.S.1, Rodriguez-Monguio R.2, Seoane-Vazquez E.1, Eguale T.3, Zeukeng M.J..4, 
Szeinbach S.5
1MCPHS University, Boston, MA, USA, 2University of Massachusetts, Amherst, Amherst, MA, 
USA, 3Brigham and Women’s Hospital, Boston, MA, USA, 4University of Geneva, Geneva, 
Switzerland, 5Ohio State University, Columbus, OH, USA
OBJECTIVES: We assessed trends in approvals of new molecular entities (NME) and 
new therapeutic biologic license applications (BLA) in the US in the period 1980-2014 
by country of incorporation of the sponsor company of the application. METHODS: 
Regulatory information for NMEs and BLA approved in the study period was derived 
from the FDA, and the country of incorporation of the sponsor companies at the date 
of drug approval was extracted from Lexis-Nexis, companies’ webpages and financial 
reports. Drugs were classified using the WHO anatomical therapeutic chemical clas-
sification system. Descriptive statistics and chi-square tests were conducted in the 
study. RESULTS: The FDA approved 103 BLA and 866 NME during the period 1980-2014. 
Five countries had an average of at least 1 BLA/NME approved per year during the 
study period: US (57.9% of all approvals), UK (10.6%), Switzerland (10.0%), Germany 
(7.1%), and Japan (3.7%). The percentage of drugs approved by US companies ranged 
from 65.9% for antiinfectives for systemic use to 38.9% for sensory organs. US com-
panies sponsored a higher number of BLA (76.7%) than NME (55.7%) (p< 0.001). Drugs 
approved by US companies varied from 62.7% in the 1980s, 56.6% in the 1990s, 58.2% in 
the 2000s, and 53.2% in the period 2010-2014. The therapeutic classes with the largest 
percentage of approvals for each country of incorporation were: dermatologicals in the 
UK (27.0% of all approvals), sensory organs in Switzerland (38.9%), respiratory system 
in Germany (18.4%), nervous system in Japan (9.4%), and genitourinary system and sex 
hormones in France (6.1%). US companies sponsored a larger percentage of orphan 
(64.8%) than non-orphan drugs (54.6%) (p< 0.001). CONCLUSIONS: Approximately 90% 
of all new drugs approved by the FDA were sponsored by companies incorporated 
in US, UK, Switzerland, Germany, and Japan, indicating that pharmaceutical R&D is 
concentrated in a few countries.
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tHe iMPaCt of tHe essential MediCine PoliCy on Patients’ HealtH 
Care Utilization and Cost in tianjin CHina: a qUasi-exPeriMental 
design
Ding L., Wu J.
Tianjin University, Tianjin, China
OBJECTIVES: The Essential Medicine Policy (EMP) was implemented to improve 
the affordability of medicines and reduce patients’ economic burden in 2009 along 
with the new round of health care reform in China. This study is to evaluate the 
effects of EMP on patients’ health care utilization and spending. METHODS: Urban 
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OBJECTIVES: This research aims to examine whether minority and/or low-income 
patients are slower to stop use of a particular medical treatment when there is 
new evidence of safety risks. METHODS: We examine the demand response of 11 
chronic medications that received first-time major safety warnings (including black 
box warnings) from the Food and Drug Administration (FDA) between July 2006 -- 
December 2009. We restrict the sample to medications that experienced decreased 
utilization post-warning and followed patients who were users of at least one of the 
11 medications. Selected Medicare beneficiaries were 18 years or older (n = 549,645), 
drawn from a random 20% sample of Medicare Part D claims data. A pooled multi-
variate logistic regression was performed on the likelihood of these patients stop-
ping use post warning (defined as having no claims of the medication between 180 
-- 360 days post warnings), controlling for patient demographics, Medicare plan type, 
new user status (naive patients or not), medication and state fixed effects. RESULTS: 
Preliminary analyses suggest that Hispanics and blacks were more likely to stop tak-
ing a medication compared to whites (ORs= 1.160 and 1.122, respectively, p< 0.001). 
By contrast, Medicare beneficiaries eligible to receive medications at little or no 
cost, i.e. dual-eligibiles and those who received low income subsidies, were less 
likely to stop than non-subsidized beneficiaries (ORs = 0.790 and 0.792 respectively, 
p< 0.001). Users who initiated their medications within 6 months before the safety 
warnings were the most likely to stop use in the post-warning period (OR = 3.759, 
p< 0.001). CONCLUSIONS: The findings suggest that socio-economic status is associ-
ated with modestly longer delays in stopping drug therapy with recent medication 
safety warnings. Specifically, low-income patients who are subsidized beneficiaries 
are less likely to stop using medications that received safety warnings and therefore 
may be subject to greater harm from adverse drug effects.
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Patient awareness and Use of MediCation gUides
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OBJECTIVES: Medication Guides are patient-directed, Food and Drug Administration 
(FDA)-approved labeling intended to provide risk and safe-use information for 
prescription medications in easy-to-read, lay language. They were introduced to 
help patients understand and manage risks and maximize benefit from products 
by aiding in decision-making and helping improve adherence to and appropri-
ate use of medications. This review was designed to assess whether patients are 
receiving medication guides per federal regulations and are able to use them as 
intended. METHODS: Knowledge, Attitudes, and Behavior (KAB) survey results in 
a heterogeneous sample of FDA-mandated REMS were reviewed to assess under-
standing of key risk messages (KRM) and receipt, reading, and understanding of 
medication guides. Results were calculated individually and compared across 
surveys. RESULTS: The review includes results from 36 patient KAB surveys for 
products in 8 therapeutic areas. Sample sizes ranged from 10-628 respondents per 
survey. Receipt: Median 89.3% (range 58.1-99.6%) of respondents reported receiving a 
medication guide. Reading: Median 93.1% (range 77.0-100.0%) of respondents report-
ing receiving a medication guide reported reading at least some of it. Understanding: 
Median 93.7% (range 36.8-100.0%) of respondents reported understanding all or 
most of what they read in the medication guide. Median 98.3% (range 64.6-100.0%) 
of respondents reported they understood all or most of what they read after having 
someone explain the information. In an objective assessment of understanding KRM 
of medication guides, median 72.4% (range 1.2-100.0%) of respondents answered 
questions correctly. CONCLUSIONS: This review demonstrates the inconsistency of 
usability of medication guides for the purposes intended as shown by the range of 
responses, particularly objective assessment of KRM understanding. Usability may 
be limited by incomplete distribution and inadequate risk communication. Data 
will be presented to discuss differences in reported and demonstrated understand-
ing and possible reasons why patients may be unable to use medication guides as 
they are intended.
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OBJECTIVES: To investigate community pharmacists’ perception towards inter 
professional learning (IPL), continue professional development (CPD) programs 
and their current clinical and professional role towards patient care in Pakistan’s 
health care system. METHODS: This study was conducted on community phar-
macists from different cities of the biggest province of Pakistan, the Punjab. Data 
was collected by convenient sampling method from all major cities of the province. 
Different statistical tests were used to analyze the obtained data. RESULTS: Around 
93.9% of the community pharmacists were involved in prescription filling, refilling 
and patient counseling in the Punjab, Pakistan. They all were willing to take part 
in IPL, CPDs and patient safety programs but majority of the pharmacist (82.8%) 
conveyed that their current role is more focusing towards the store manager, buy-
ing and selling of the medicines and inventory control. Surprisingly, 75% of them 
were not aware about IPL and CPDs. CONCLUSIONS: The findings from this study 
